Original Research
Published on 12 Jul 2022
Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination
in Neuro-Oncology and Neurosurgical Oncology
- 2,058 views
- 5 citations